M&A

Essential Pharma Acquires Reminyl (galantamine hydrobromide) Oral Capsules from Janssen

Essential Pharma Acquires Reminyl (galantamine hydrobromide) Oral Capsules from Janssen

Shots: Essential Pharma has completed the acquisition of Reminyl oral capsules fro...

Vertex to Acquire Alpine Immune Sciences for ~$4.9B

Vertex to Acquire Alpine Immune Sciences for ~$4.9B

Shots: Vertex has signed a definitive agreement to acquire Alpine Immune Sciences...

Johnson & Johnson Reports the Acquisition of Shockwave Medical to Strengthen its MedTech Cardiovascular Portfolio

Johnson & Johnson Reports the Acquisition of Shockwave Medical to Strengthen its MedTech Cardiovascular Portfolio

Shots: Johnson & Johnson has signed a definitive agreement to acquire Shockwav...

ARCA Biopharma Signs a Definitive Merger Agreement with Oruka Therapeutics to Develop Biologics for Chronic Skin Diseases

ARCA Biopharma Signs a Definitive Merger Agreement with Oruka Therapeutics to Develop Biologics for Chronic Skin Diseases

Shots: As per the agreement, the pre-merger ARCA stockholders will hold ~2.38% of...

Genmab to Acquire ProfoundBio for Enhancing its Oncology Portfolio

Genmab to Acquire ProfoundBio for Enhancing its Oncology Portfolio

Shots: Genmab has signed a definitive agreement to acquire ProfoundBio for an aggr...

Juvisé Pharmaceuticals Reports the Acquisition of Actelion’s Ponvory (ponesimod) for the Treatment of Multiple Sclerosis (MS)

Juvisé Pharmaceuticals Reports the Acquisition of Actelion’s Ponvory (ponesimod) for the Treatment of Multiple Sclerosis (MS)

Shots: Juvisé acquired the rights to Ponvory from Actelion Pharmaceutical (...

Image